Skip to main content
Year archive

Cellid Co., Ltd. — 2023 filings

All 77 regulatory filings released by Cellid Co., Ltd. (299660) in 2023, sourced directly from the official regulator.

77 Filings
2023 Period
2023 filings (77)
Filing Released Lang
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2023-12-20 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2023-12-19 Korean
투자판단관련주요경영사항(임상시험계획승인신청)(항암면역치료백신 BVAC-E6E7의 제1/2a상 임상시험 계획 승인신청)
Regulatory Filings
2023-12-18 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2023-12-14 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-12-08 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-12-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-12-08 Korean
자산재평가실시결정(자율공시)
Regulatory Filings
2023-11-16 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-14 Korean
투자판단관련주요경영사항(임상시험결과)(항암면역치료백신 BVAC-C의 제2a상 임상시험)
Legal Proceedings Report
2023-09-21 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-09-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-09-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-09-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-09-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-09-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-09-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-09-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-09-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-09-15 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2023-09-14 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-09-11 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-09-11 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-09-11 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-09-11 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-09-11 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-09-11 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-09-11 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-09-11 Korean
전환가액의조정
Share Issue/Capital Change
2023-09-11 Korean
증권발행결과(자율공시)
Share Issue/Capital Change
2023-09-08 Korean
증권발행실적보고서
Share Issue/Capital Change
2023-09-08 Korean
유상증자또는주식관련사채등의청약결과(자율공시)
Share Issue/Capital Change
2023-09-07 Korean
유상증자또는주식관련사채등의청약결과(자율공시)
Share Issue/Capital Change
2023-09-04 Korean
[기재정정]투자설명서
Investor Presentation
2023-08-29 Korean
유상증자최종발행가액확정
Capital/Financing Update
2023-08-29 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-08-29 Korean
[발행조건확정]증권신고서(지분증권)
Capital/Financing Update
2023-08-29 Korean
[기재정정]투자설명서
Capital/Financing Update
2023-08-29 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-11 Korean
[기재정정]증권신고서(지분증권) (2023.08)
Capital/Financing Update
2023-08-11 Korean
기업설명회(IR)개최
Report Publication Announcement
2023-08-10 Korean
기업설명회(IR)개최
Report Publication Announcement
2023-08-10 Korean
투자판단관련주요경영사항(임상시험계획승인신청등결정)(COVID-19 예방 백신 AdCLD-CoV19-1 OMI의 제3상 임상시험 계획(IND) 승인)
Regulatory Filings
2023-07-21 Korean
투자설명서
Capital/Financing Update
2023-07-17 Korean
유상증자1차발행가액결정
Capital/Financing Update
2023-07-17 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-07-17 Korean
[발행조건확정]증권신고서(지분증권)
Capital/Financing Update
2023-07-17 Korean
[기재정정]투자설명서
Capital/Financing Update
2023-07-17 Korean
권리락(유상증자)
Share Issue/Capital Change
2023-07-17 Korean
투자판단관련주요경영사항(임상시험결과)(COVID-19 예방 백신 AdCLD-CoV19-1 OMI의 제1/2상 임상시험 Top-line 결과 발표)
Legal Proceedings Report
2023-07-14 Korean
신규시설투자등
Share Issue/Capital Change
2023-07-07 Korean
타인에대한담보제공결정
Capital/Financing Update
2023-07-07 Korean
[기재정정]증권신고서(지분증권) (2023.08)
Capital/Financing Update
2023-06-30 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-06-16 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-06-16 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-06-16 Korean
증권신고서(지분증권) (2023.08)
Capital/Financing Update
2023-06-16 Korean
투자판단관련주요경영사항(임상시험계획승인신청)(COVID-19 예방 백신 AdCLD-CoV19-1 OMI의 제3상 임상시험 계획(IND) 신청)
Regulatory Filings
2023-05-23 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-15 Korean
기타경영사항(자율공시)(국책과제 선정(아데노바이러스 벡터 플랫폼 기반 COVID-19 변이에 대한 다가백신 개발))
Regulatory Filings
2023-05-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-04-05 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-04-05 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-29 Korean
투자판단관련주요경영사항(코로나바이러스감염증-19(COVID-19) 예방 백신 AdCLD-CoV19 제1/2a상 임상시험 결과)
Legal Proceedings Report
2023-03-27 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2023-03-24 Korean
투자판단관련주요경영사항(코로나바이러스감염증-19(COVID-19) 예방 백신 AdCLD-CoV19-1 제1상 임상시험 결과)
Regulatory Filings
2023-03-21 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-21 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-21 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2023-03-20 Korean
단일판매ㆍ공급계약체결
Regulatory Filings
2023-03-16 Korean
주주총회소집공고
AGM Information
2023-03-14 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-03-14 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2022
2023-02-23 Korean
파생상품거래손실발생
Legal Proceedings Report
2023-02-23 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2023-02-23 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-02-23 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change
2023-02-17 Korean